Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
beta blocker |
| gptkbp:approvedBy |
1983
|
| gptkbp:ATCCode |
C07AB05
|
| gptkbp:CASNumber |
63659-18-7
|
| gptkbp:developedBy |
gptkb:Synthelabo
|
| gptkbp:eliminationHalfLife |
14-22 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C18H29NO3
|
| https://www.w3.org/2000/01/rdf-schema#label |
betaxolol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
selective beta-1 adrenergic receptor antagonist
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
topical (eye drops) |
| gptkbp:sideEffect |
dizziness
fatigue hypotension bradycardia |
| gptkbp:synonym |
Betoptic
Kerlone |
| gptkbp:usedFor |
hypertension
glaucoma |
| gptkbp:bfsParent |
gptkb:Beta-1_adrenergic_receptor
|
| gptkbp:bfsLayer |
7
|